Kite, a Gilead Company (Nasdaq:GILD) and Sangamo Therapeutics, Inc. (Nasdaq:SGMO) today announced the companies have entered into a worldwide collabor.

Kite, a Gilead Company (Nasdaq: GILD), and HiFiBiO Therapeutics, a biotechnology company focused on the discovery of therapeutic antibodies through si ...

SANTA MONICA, Calif.& PHILADELPHIA---- Kite, a Gilead Company, ... Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer ...

As Juno Therapeutics (NASDAQ: JUNO) and Kite Pharma (NASDAQ: KITE) ramp up for a potential 2017 or early 2018 launch of their lead CAR-T therapies, investor caution is advised.Although the ...

Amsterdam-based Neogene Therapeutics Inc., which was founded in 2018, announced May 24 that it has leased 38,000 square feet of space in two buildings in Santa Monica.

Shares of Juno Therapeutics (JUNO) continued to soar on Tuesday. The stock has now gained nearly 40% since the announcement that fellow CAR-T cancer therapy designer Kite Pharma (KITE) is being ...

Juno Therapeutics Is Not Kite Pharma; We Are Short Juno. Aug. 30, 2017 8 ... We stand by our short call on Juno being a far different company from Kite Pharma with a CAR-T development stage ...

SANTA MONICA, Calif. and RICHMOND, Calif., Feb. 22, 2018 /PRNewswire/ -- Kite, a Gilead Company (Nasdaq: GILD) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the companies have ...

* KITE, A GILEAD COMPANY, AND SANGAMO THERAPEUTICS ANNOUNCE COLLABORATION TO DEVELOP NEXT-GENERATION ENGINEERED CELL THERAPIES FOR THE TREATMENT OF CANCER * SANGAMO THERAPEUTICS - KITE TO RECEIVE ...

Kite, a Gilead Company (Nasdaq:GILD) and Sangamo Therapeutics, Inc. (Nasdaq:SGMO) today announced the companies have entered into a worldwide collaboration using Sangamo’s zinc finger nuclease ...